Accessibility Menu
Encision logo

Encision(OTC) ECIA

Current Price$0.05
Market Cap$763.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)-100%
5 Year-95%
1 Year-88%
1 Month+2,913%
Encision last closing stock price
MetricPriceDate
Last closeUSD 0.052026-07-16
Encision stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2,913.33%USD 0.002026-06-15
1 month+2,913.33%USD 0.002026-06-15
3 month-77.51%USD 0.202026-04-16
Year to date-67.71%USD 0.142025-12-30
1 year-87.65%USD 0.372025-07-11
3 year-89.75%USD 0.442023-07-17
5 year-94.68%USD 0.852021-07-15
Since inception-99.57%USD 10.501996-06-25

Encision Financials at a Glance

Market Cap

$763.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$5.93M

Net Income (TTM)

-$332.01K

EPS (TTM)

-$0.03

P/E Ratio

-1.59

Dividend

$0.00

Beta (Volatility)

-39.33 (Low)

Price

$0.05

Volume

2,000

Open

$0.05

Previous Close

$0.05

Daily Range

$0.05 - $0.05

52-Week Range

$0.00 - $0.40

Estimated Earnings Date

Jul 19, 2026

ECIA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Encision

Encision makes surgical tools that help prevent burns during keyhole surgeries. Hospitals use these tools to improve patient safety. The company’s products aim to reduce risks for both patients and surgeons.

Tools of the Trade: What Encision Sells

  • AEM Surgical Instruments: Laparoscopic scissors, graspers, and dissectors with safety features; over 90% of product revenue in Q1 FY2026; used by hospitals and surgery centers.
  • Burn Protection Systems: EndoShield 2 system helps prevent accidental burns during surgery; used in minimally invasive procedures.
  • Monitoring Devices: AEM monitors work with Encision’s instruments to detect stray electrical energy; used in operating rooms.
  • Instrument Handles: Ergonomic handles for advanced procedures; designed for surgeon comfort and control.
  • Engineering Services: Custom engineering for partners like Vicarious Surgical; 6.9% of revenue in Q1 FY2026.

Growth Spurts and New Directions

  • Launched next-generation AEM products, including disposable scissors, in 2025-2026.
  • Expanded engineering services through a Master Services Agreement with Vicarious Surgical in 2025.
  • Invested in new manufacturing equipment to lower costs in 2025.
  • Explored international markets and licensing opportunities in 2025-2026.
  • Placed monitors in hospitals at no charge to encourage product adoption in 2025.

What Makes Encision Stand Out

Encision’s patented technology addresses a specific surgical safety risk not covered by standard tools. Its products fit seamlessly into existing hospital workflows, requiring no change in surgeon technique. The company generates recurring revenue from hospitals that regularly replace instruments and accessories.

Five Things You Need to Know

  • Revenue was $2 million in Q1 FY2026, down 1.7% from Q1 FY2025.
  • Gross profit was $878,459 in Q1 FY2026, down 6.8% year-over-year.
  • Operating loss was $19,780 in Q1 FY2026, compared to income last year.
  • Cash used in operations was $115,508 in Q1 FY2026, down from $117,528 provided in Q1 FY2025.

Bottom Line

Encision focuses on surgical safety with patented tools and a recurring revenue model. The company faces ongoing challenges but continues to adapt its product line and operations.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

24

CEO

Robert H. Fries, MBA

Website

www.encision.com

Headquarters

Boulder, CO 80301, US

ECIA Financials

Key Financial Metrics (TTM)

Gross Margin

51.55%

Operating Margin

-4.52%

Net Income Margin

-5.60%

Return on Equity

-20.14%

Return on Capital

-20.35%

Return on Assets

-9.46%

Earnings Yield

-62.89%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$763.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

16.88M

Volume

2.00K

Avg. Volume

471.274

Financials (TTM)

Gross Profit

$3.06M

Operating Income

-$268.05K

EBITDA

-$184.62K

Operating Cash Flow

-$280.03K

Capital Expenditure

$14.37K

Free Cash Flow

-$265.66K

Cash & ST Invst.

$170.76K

Total Debt

$1.56M

Encision Performance Analysis

Encision annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 7,348,514-4.2%
20242024-03-31USD 6,585,882-10.4%
20252025-03-31USD 6,555,315-0.5%
20262026-03-31USD 5,784,191-11.8%
Encision sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-03-31-0.1%
Q12025-06-301.2%
Q22025-09-30-4.7%
Q12026-06-30N/A
Encision annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -0.03391.1%
20242024-03-31USD -0.06113.8%
20252025-03-31USD -0.02-68.5%
20262026-03-31USD -0.05161.1%
Encision sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-03-31-90.5%
Q12025-06-3012.5%
Q22025-09-30-440.0%
Q12026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

$1.22M

-23.3%

Gross Profit

$591.56K

-30.4%

Gross Margin

48.62%

N/A

Market Cap

$763.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$34.68K

N/A

Employees

22

N/A

Net Income

$24.26K

+198.4%

EBITDA

$55.49K

+32542.9%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

$170.76K

-50.9%

Total Debt

$1.56M

+19.2%

Accounts Receivable

$578.72K

-25.8%

Inventory

$1.34M

-1.4%

Long Term Debt

$779.50K

+39.2%

Short Term Debt

$782.07K

+4.2%

Return on Assets

-9.46%

N/A

Return on Invested Capital

-11.99%

N/A

Free Cash Flow

-$43.08K

-406.1%

Operating Cash Flow

-$37.89K

+17.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PAIYYAesthetic Medical International Holdings Group Limited
$0.02+0.00%
REPCFRepliCel Life Sciences Inc.
$0.00+0.00%
RDDTFRadient Technologies Inc.
$0.00+0.00%
HAVLFHAVN Life Sciences Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
NOKNokia
$9.10-0.06%
STAKStak
$9.27+6.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$64.00-0.03%

Questions About ECIA

What is the current price of Encision?

Encision is trading at $0.05 per share.

What is the 52-week range for Encision?

Over the past 52 weeks, Encision has traded between $0.00 and $0.40.

How much debt does Encision have?

As of the most recent reporting period, Encision reported total debt of $1.56M.

How much cash does Encision have on hand?

Encision reported $170.76K in cash and cash equivalents in its most recent financial results.

What is Encision’s dividend yield?

Encision does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services